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Edited by Lukas HuberAbstract We describe the creation of cell adhesion mediated by
cell surface engineering. The Flt3-ligand was fused to a mem-
brane anchor made of the diphtheria toxin translocation domain.
The fusion protein was attached to the surface of a cell by an
acid pulse. Contact with another cell expressing the receptor
Flt3 lead to its activation. This activity involved direct cell–cell
contact. A mean force of 20 nN was needed to separate function-
alized cells after 5 min of contact. Overall, we showed that it is
possible to promote speciﬁc cell–cell adhesion by attaching pro-
tein ligands at the surface of cells.
 2007 Federation of European Biochemical Societies.
Published by Elsevier B.V. All rights reserved.
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Cell surface engineering is of great potential in the develop-
ment of cell therapies. This enables for instance the manipula-
tion of cell adhesion, recognition, signalling, and stimulation.
The display of novel proteins on the surface of cells is generally
obtained by introducing genes into them. The expression of a
protein with a signal sequence and a transmembrane sequence
ensures proper targeting to the cell membrane. However,
transfection eﬃciency and the degree of expression vary greatly
from one cell type to another. In addition, the genetic manip-
ulation of cells for therapeutic applications is not devoid of
risk [1].
The diphtheria toxin translocation (T) domain can be used
as a low-pH-activated membrane anchor to attach proteinsAbbreviations: FL, Flt3-ligand; T, translocation
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eties. Puto the cell surface [2,3]. The T domain, which is soluble at neu-
tral pH, inserts itself irreversibly in cell membranes at acid pH.
If a soluble protein is fused to its N- or C-terminal end, and
incubated with cells at acid pH, it will attach to the plasma
membrane. In the present work, we demonstrate the possibility
of creating bonds between cells using this technique. We
created adhesion mediated by speciﬁc interaction between a
ligand anchored on the surface of a cell and its receptor
expressed on the surface of another cell.
We fused the T domain of diphtheria toxin to Flt3-ligand
(FL), a cytokine active in its homodimeric form [4,5] and syn-
thesized by numerous cell types in biologically active soluble
and membrane forms [6,7]. FL is involved in the proliferation
of hematopoietic stem cells, the only cells that have the Flt3
receptor, boosting the number of myeloid and lymphoid den-
dritic cells [8], and natural killer cells [9].
We anchored active FL to the surface of tumor cells and
tested the recognition of FL-bearing cells by cells expressing
the Flt3 receptor. We showed that FL remains active after
fusion to the T domain, and anchoring to the cell surface.
We demonstrated direct adhesion between FL-carrying cells
and target cells bearing the Flt3 receptor and measured the
interaction force engaged in the cell–cell interaction.2. Materials and methods
2.1. Expression and puriﬁcation of proteins FL and FLT
The cDNA of FL was from the Core Facility Lab of the University
of Michigan. The sequence encoding the T domain was from the plas-
mid pA/T [2]. The cDNA of FL and of the T domain were ampliﬁed by
PCR and fused behind the T7 promoter in a vector of the pET series
(Novagen), to give the plasmid pFLT. The vector pFL allowing
expression of isolated FL was derived from pFLT by deletion of the
sequence coding for the T domain. The coding sequence of these two
proteins is preceded by a polyhistidine sequence (MH6G). A ﬂexible
and hydrophilic arm (H6ANS3GSG2SG2SGSGI2YPG) separates the
two domains of FLT. This sequence contains a 6 His Tag, which comes
from the initial sequence of the T domain from plasmid pA/T used to
construct the plasmid pFLT.
Proteins were expressed in Escherichia coli Rosetta (Novagen) in
culture medium containing 0.2 mg/ml ampicillin and 0.025 mg/ml
chloramphenicol and puriﬁed as described previously for T-IL3 [10].
Before puriﬁcation, the protein extract was sulfonated by addition of
sodium sulﬁte over 20 min to a ﬁnal concentration of 0.3 M, and then
addition of 50 mM disodium 2-nitro-5-thiosulfobenzoate for 1 h to re-
duce the disulﬁde bridges and block free cysteine residues [11]. The
protein was puriﬁed as a monomer by ion metal aﬃnity chromatogra-
phy under denaturing condition using its N-terminal 6 His tag.blished by Elsevier B.V. All rights reserved.
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Puriﬁed proteins (0.5 mg/mL) were dialyzed against 6 M GdnHCl,
0.1 M Tris–HCl, pH 8, and then four times (12 h each time, 4 C, pro-
tected from light) against 0.9 M GdnHCl, 4 mM EDTA, 0.1 M Tris–
HCl, pH 8.3, 10% glycerol, 8 mM cysteine, 1 mM cystine. The dialyzed
extract was centrifuged for 1 h at 4500 rpm to remove precipitate. The
protein solution was dialyzed against 2.5 l of PBS-10% glycerol, pH
7.4, centrifuged again, and concentrated to an approximate concentra-
tion of 105 M, using an Amicon cell (Millipore) ﬁtted with a mem-
brane of molecular cut-oﬀ 10 kDa. Proteins were stored at 20 C.
2.3. Cell lines and proliferation tests
RMA T lymphoma and Ba/F3 4G1 cells were grown in RPMI 1640
containing 10% fetal calf serum and 2 mM glutamine in the presence of
murine IL-3 for Ba/F3 4G1 cells.
Proliferation tests were done on Ba/F3 4G1 cells as described previ-
ously [10,12].
2.4. Anchoring of FLT to the surface of RMA cells
RMA cells (107) washed in PBS were incubated for 1 h at room tem-
perature with increasing concentrations of FLT, with shaking in
1.5 mL of PBS-citrate at pH 4.7. The cells were washed 4 times in
10 mL of PBS pH 7.4 and stored at 4 C. If necessary, and to block
their proliferation before anchoring, the RMA cells were treated over-
night with 3 lg/mL mitomycin C (Sigma–Aldrich) in the culture med-
ium, and washed 4 times in PBS.
2.5. Flow cytometry detection of FLT anchoring to the membrane
For each test, 3 · 105 cells were washed, resuspended in 100 lL of
PBS, and incubated for 30 min at 4 C with goat anti-FL polyclonal
antibodies (R&D Systems) diluted 1/50. The cells were washed in
PBS and incubated for 30 min on ice and protected from light with a
secondary phycoerythrin-coupled antibody (Jackson ImmunoRe-
search) diluted 1/50. The cells were then washed and resuspended in
PBS. Samples were analyzed in a FACSCalibur ﬂow cytometer (Bec-
ton–Dickinson) using CellQuest Pro software.
2.6. Dual pipette aspiration technique to test cell–cell interaction
We used dual pipette assay to quantify the strength of cell–cell adhe-
sion. The experiments were performed on the stage of a Leica inverted
microscope, equipped with ·10 and ·63 objectives and positioned on
an anti-vibration platform. The incubation chamber consisted of the
bottom of a 90-mm Petri dish coated with BSA and ﬁlled with com-
plete RPMI medium. RMA cells loaded with FLT at a concentration
of 106 M and Ba/F3 4G1 cells were each gently deposited at two dif-
ferent places of the experimental chamber in order they did not mix.
Micropipettes were obtained by pulling (with a Sutter instrument,
model P-2000), cutting and ﬁre-polishing glass capillaries with a home-
made microforge. Micropipettes were coated with BSA. Cells were
manipulated with two such micropipettes of 4–6 lm internal diameter,Fig. 1. (A) FL activity of the recombinant proteins FL (d) and FLT (m). P
incorporation. (B) Detection by ﬂow cytometry of the binding of FLT to t
3 · 106 M; orange 106 M; green, 3 · 107 M; light green, 107 M. Inset: de
106 M. (C) Proliferation of Ba/F3 4G1 cells in the presence of RMA cells car
C and incubated for 1 h at pH 4.7 with the recombinant proteins FLT (m)
Proliferation of the Ba/F3 4G1 cells was measured by [3H] Thymidine incoreach held in its own micromanipulator and connected to a combined
hydraulic/pneumatic system that provided the necessary control of
the aspiration force applied to the cells. The protocol we used is very
similar to that of Chien and co-workers [13]. An RMA cell and a
Ba/F3 4G1 cell, collected by gentle aspiration onto the tip of each pip-
ette, were brought into contact through the use of the micromanipula-
tors and allowed to remain in contact for 5 min. To separate the cells,
aspiration in the right pipette was maintained at a level suﬃciently high
to hold the RMA cell tightly, while the aspiration in the left pipette was
increased in steps measured with a pressure sensor (Validyne: model
DP103–38; ranging from 0 to 50000 Pa). After each step, the pipettes
were moved apart in an eﬀort to detach the adherent cells from one an-
other. A pair pulled intact from the left pipette by the right pipette was
moved back to the left pipette oriﬁce, the aspiration in this pipette was
increased, and another attempt was made to detach the cells from each
other. The cycle was repeated until the level of aspiration in the left
pipette was suﬃcient to pull one cell apart from the other. The aspira-
tion employed in each cycle was monitored continuously. In most
cases, cell deformation and contact area variation during the separa-
tion process were very limited (less than 20% for the contact area),
and the separation took place suddenly, in less than a tenth of a sec-
ond. The values recorded for each of the last two cycles in the series
(Pn1 and Pn) were used to calculate the separation force, Fs with equa-
tion F s ¼ ðDPn1 þ DPnÞpr2p=2, where DPn1 and DPn are respectively
the aspiration in the left pipette at cycles n  1 and n, and rp, its inter-
nal radius. This relation assumes that the pressure inside the cell is the
same as that in the chamber; valid in our case since the tension of the
cell is essentially zero.3. Results
3.1. FL activity of recombinant proteins FL and FLT
Two recombinant proteins called FL and FLT were pro-
duced. Human FL was used as control. FLT was human FL
fused to the N-terminal end of the diphtheria toxin T domain.
The N-terminal end was chosen to reproduce the organization
of the natural membrane form of FL, its transmembrane
sequence being at the C-terminal end [5].
To assess the structural and functional integrity of FL in the
fusion protein, we tested the capacity of the recombinant pro-
teins FL and FLT to recognize and activate the Flt3 receptor.
Ba/F3 4G1 cells transfected with the Flt3 receptor gene were
incubated with increasing concentrations of proteins. Cell
growth was measured by incorporation of tritiated thymidine.
Fig. 1A shows that FL (d) and FLT (m) concentration-depen-
dently induced proliferation of Ba/F3 4G1 cells. The EC50 val-roliferation of the Ba/F3 4G1 cells was measured by [3H] Thymidine
he surface of RMA cells as a function of protein concentration: red,
tection of FL to the surface of RMA cells at a protein concentration of
rying FLT. RMA cells were treated overnight with 3 lg/mL mitomycin
and FL (d) at a protein concentration of 106 M or no proteins (s).
poration.
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ity) of FL and FLT were, respectively, 1010 M and
2 · 109 M. FLT was therefore 20 times less active than FL.
The proliferation-inducing activity of FL and FLT was con-
centration-dependently inhibited by an antibody directed
against FL (data not shown). These results indicate that re-
combinant FL and FLT bind to and speciﬁcally activate the
Flt3 receptor. They are therefore correctly folded as a homodi-
mer, which is the active form of FL [5]. Steric hindrance related
to the presence of the T domain and the N-terminal 6 His tag
probably explains why FLT is less active than FL.
As the fusion protein is anchored to cell membranes at acid
pH, we tested the eﬀect of acid treatment on its FL activity. FL
activity of FLT was preserved after 1 h treatment at pH 4.7
(not shown).
3.2. Anchoring of FLT to the surface of RMA cells
RMA cells were incubated for one hour at pH 4.7 with
increasing concentrations of protein FLT. Binding of FLT to
the cell surface was studied by ﬂow cytometry (Fig. 1B). The
results show that FLT binds to RMA cells at acid pH, in
amounts that depend on the FLT concentration used in the
incubation. Since FL incubated with the cells in the same con-
ditions is weakly detected at their surface (inset) membrane
binding is due to the presence of the T domain.
3.3. FL activity of FLT-carrying RMA cells
We tested whether RMA cells loaded with FLT at acidic pH
would stimulate the proliferation of Ba/F3 4G1 cells (Fig. 1C).
RMA cells were treated with mitomycin C to block their pro-Fig. 2. Measurement of the force needed to separate RMA cells carrying the
the Flt3 receptor. (A) Aspiration in the right pipette was maintained at a level
left pipette (Ba/F3 4G1) was increased in steps. At each step, the right pipette
the left pipette is weaker than the adhesive force between the two cells, the dou
This procedure was repeated with increasing suction in the left pipette until t
two suction forces. (B) Probability density of the force needed to separate Rliferation. The results show that RMA cells carrying FLT in-
duced proliferation of Ba/F3 4G1 cells (m). This induction
intensiﬁed with an increase in number of RMA cells, compared
with Ba/F3 4G1 cells, and with an increase in FLT concentra-
tion used in membrane anchoring (not shown). In contrast,
RMA cells incubated with FL (d) did not stimulate Ba/F3
4G1 cells.
The supernatant of cells carrying FLT was tested on Ba/F3
4G1 cells for the presence of soluble FL activity. Some activity
was found (not shown), indicated that some of the FLT mole-
cules bound to the RMA cells were shed in the medium. But
the majority of the FL activity carried by the Ba/F3 4G1 cells
was due to molecules attached to their surface. This suggested
that direct cell–cell contacts were involved in the stimulation.
3.4. Detection of a cell–cell interaction
We used a dual micropipette assay to investigate the occur-
rence of intercellular contacts. For that, the force required to
separate a FLT-bearing RMA cell and a Ba/F3 4G1 cell was
measured and compared to that measured as a control with
a T-IL2-bearing RMA cell and a Ba/F3 4G1 cell. Anchoring
of the cytokine IL2 to the surface of cells using the T domain
fused to its N-terminal end has been described previously [12].
For each pair of cells, the two cells held by gentle aspiration at
the tips of two micropipettes were ﬁrst brought into contact for
5 min. Fig. 2A illustrates an example of a cell doublet obtained
after 5 min of contact, the right pipette withdrawn to visualize
the resulting adhesion. Such a doublet was cyclically brought
back into contact with the left pipette and then withdrawn to
the right, each time after a step-wise increase in the strengthrecombinant proteins FLT or T-IL2 from Ba/F3 4G1 cells expressing
suﬃciently high to hold the RMA cell tightly while the aspiration in the
was displaced in order to try to separate the cells. If the suction force in
blet remains intact and Ba/F3 4G1 cell detaches from the micropipette.
he two cells separated. The separation force was deduced from the last
MA cells carrying FLT or T-IL2 and Ba/F3 4G1 cells.
A. Perier et al. / FEBS Letters 581 (2007) 5480–5484 5483of aspiration by the left pipette, until the cells were separated
(see Section 2). The separation force Fs was deﬁned as the aspi-
ration force required in the left pipette to separate the doublet,
such that one cell remained in each pipette when the right pip-
ette was withdrawn. Fs was considered to be zero for pairs of
cells that did not form adherent doublets in this assay.
Fig. 2B shows the histogram of separation forces obtained
for 32 FLT-bearing RMA and Ba/F3 4G1 paired cells.
Regarding their adhesive properties, two populations of dou-
blets could be observed. One minority (25%) of the paired cells
could be separated immediately upon withdrawal of the right
pipette therefore no separation force could be measured.
But the majority (75%) of the paired cells formed adherent
doublets. The mean force required to separate them after
5 min of contact was 20 nN. By contrast, interaction between
T-IL2-bearing RMA and Ba/F3 4G1 cells was almost never
detected (Fig. 2B).4. Discussion
A fusion protein (FLT) formed by joining FL to the N-ter-
minal end of the diphtheria toxin T domain has the biological
properties of both proteins. Thus FLT binds to cell mem-
branes at acid pH through the T domain (Fig. 1B), in a con-
centration-dependent manner. This membrane form of FL is
still able to stimulate target cells carrying the Flt3 receptor
(Fig. 1C). It therefore mimics the natural membrane form of
FL. The properties of FLT are comparable to those of proteins
T-IL2 and T-IL3 [10,12]. In the case of FL, the fusion of the T
domain and membrane anchoring still allow dimerization of
FL, which is only active as a homodimer [5].
We used a dual pipette assay to quantify intercellular adhe-
sion in terms of mechanical forces at the cellular level and to
investigate a potential adhesion that would speciﬁcally be sup-
ported by FLT and its Flt3 receptor. The force required to sep-
arate FLT-bearing RMA and Flt3-expressing Ba/F3 4G1
paired cells was measured as an index of an interaction
speciﬁcally regulated by a membrane form of FL and its Flt3
receptor. Comparison with T-IL2-bearing RMA and Flt3-
expressing Ba/F3 4G1 paired cells were done. T-IL2-bearing
RMA cells is a good control since it provides similar mechan-
ical and steric conditions as FLT-bearing RMA cells. For both
types of cells, non-speciﬁc interactions are therefore expected
to be the same. Moreover, any diﬀerence in adhesive behaviour
of T-IL2-bearing RMA and Ba/F3 4G1 paired cells and FLT-
bearing RMA and Ba/F3 4G1 paired cells should come from
FL/Flt3 speciﬁc eﬀects. Results obtained with the dual pipette
assay (Fig. 2) showed that most of the FLT-bearing RMA and
Ba/F3 4G1 paired cells were adherent while the T-IL2-bearing
RMA and Ba/F3 4G1 doublets in the same conditions were
not. The latter observation indicates that non-speciﬁc interac-
tions between RMA and Ba/F3 4G1 cells are negligible. The
comparison between both types of doublets provides a direct
experimental evidence of the ability for membrane anchored
FLT to interact with Flt3 receptors through cellular contacts.
The mean force required to separate FLT-anchoring RMA
and Flt3-expressing Ba/F3 4G1 paired cells after 5 min of con-
tact is about 20 nN. Qualitatively, this separation force is com-
parable to forces needed to separate cells expressing (by
transfection) either natural adhesion proteins such as E-cad-
herins [14,15], or some chemokines that function as adhesionmolecules [16]. More accurate comparison would be hazardous
because each of these studies involve diﬀerent cell lines that can
give rise to diﬀerent non-speciﬁc interactions and also because
the number of proteins that control cell adhesion (i.e. proteins
in the contact area) is unknown in all cases. However, such a
level of adhesion means that soluble protein ligands attached
at the membrane of cells through the low-pH-activated T do-
main membrane anchor can engage with their receptor present
at the surface of another cell thereby generating signiﬁcant cel-
lular adhesion.
In this cellular context, the dual pipette assay has not only
proved that membrane anchored FLT can interact with Flt3
receptors through cellular contacts but to our knowledge it is
the ﬁrst time that cell/cell adhesion generated by membrane an-
chored proteins have been established and quantiﬁed.
The anchoring of receptor ligands to the surface of cells
opens the way to the engineering of cell surfaces, with a view
to manipulating cell interactions and communication. This ap-
proach has the advantage that it does not require the transfer
of genetic material, and so does not alter the cell’s genetic
make-up.
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